Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

Clinical trial NCT01120002 · UNKNOWN

Trial details

NCT number: NCT01120002
Sponsor: Osaka City University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2010-05-01
Primary completion: 2012-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.